We asked whether the CD19-4D5scFv redirected CD19-CAR T cells show a superior safety profile than the 4D5scFv-CAR T cells, with respect to discriminating between the ErbB2low healthy cells and the ErbB2high cancer cells. Here, CD19 is linked to cancer.